AirSculpt Technologies, Inc.
NASDAQ:AIRS · NASDAQ Global Market
+$0.21 today
Vol 0.85M · Avg 1.46M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:AIRS · Revenue to Net Income
Key Ratios
Analysis
$151.8M of revenue converted into -$11.2M of net income for the selected period. Gross margin is 60.5% and net margin is -7.7%, showing how much revenue survives after costs and taxes. EPS is $-0.18, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $151.8M -15.8% | $180.3M -7.9% | $195.9M +16.1% | $168.8M +26.6% | $133.3M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $61.7M -13.6% | $71.4M -3.6% | $74.0M +27.0% | $58.3M +30.9% | $44.5M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $90.1M -17.3% | $109.0M -10.6% | $121.9M +10.3% | $110.5M +24.5% | $88.8M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 59.4% -1.1pp | 60.4% -1.8pp | 62.2% -3.2pp | 65.5% -1.1pp | 66.6% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $82.2M -22.2% | $105.6M -2.5% | $108.3M +2.2% | $105.9M +61.1% | $65.7M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $95.0M -14.3% | $110.8M -1.5% | $112.4M -2.3% | $115.1M +57.6% | $73.0M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $12.8M +7.5% | $11.9M +15.9% | $10.3M +27.2% | $8.1M +22.2% | $6.6M | $374.2M | $1.2B | $631.8M |
| EBITDA | $1.2M -87.9% | $10.1M -49.0% | $19.7M +329.5% | $4.6M -79.5% | $22.4M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 0.8% -4.8pp | 5.6% -4.5pp | 10.1% +7.4pp | 2.7% -14.1pp | 16.8% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$4.8M -166.1% | -$1.8M -119.2% | $9.5M +308.6% | -$4.5M -128.8% | $15.8M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -3.2% -2.2pp | -1.0% -5.8pp | 4.8% +7.5pp | -2.7% -14.5pp | 11.8% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $6.1M -2.7% | $6.2M -3.7% | $6.5M -3.9% | $6.8M +38.1% | $4.9M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$12.8M -105.0% | -$6.2M +3.7% | -$6.5M +3.9% | -$6.8M -38.1% | -$4.9M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$17.6M -118.8% | -$8.1M -368.9% | $3.0M +126.5% | -$11.3M -203.8% | $10.9M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -11.6% -7.1pp | -4.5% -6.0pp | 1.5% +8.2pp | -6.7% -14.9pp | 8.2% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$6.0M -3276.1% | $188.0K -97.5% | $7.5M +121.0% | $3.4M +928.3% | $329.0K | $1.3B | -$1.6B | $745.2M |
| Net Income | -$11.7M -41.4% | -$8.3M -84.2% | -$4.5M +69.5% | -$14.7M -239.1% | $10.6M | $4.9B | $4.8B | $4.7B |
| Net Margin | -7.7% -3.1pp | -4.6% -2.3pp | -2.3% +6.4pp | -8.7% -16.6pp | 7.9% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$0 -35.7% | -$0 -77.4% | -$0 +69.7% | -$0 -3562.0% | -$0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$0 -35.7% | -$0 -77.4% | -$0 +69.7% | -$0 -3562.0% | -$0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $60.5M +4.8% | $57.7M +1.6% | $56.8M +2.0% | $55.7M +0.1% | $55.6M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $60.5M +4.8% | $57.7M +1.6% | $56.8M +2.0% | $55.7M +0.1% | $55.6M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
MoonLake Immunotherapeutics
NASDAQ:MLTX
$1.42B
InnovAge Holding Corp.
NASDAQ:INNV
$1.25B
COMPASS Pathways plc
NASDAQ:CMPS
$1.20B
AMN Healthcare Services, Inc.
NYSE:AMN
$1.20B
SI-BONE, Inc.
NASDAQ:SIBN
$694.95M
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$461.28M
Pacific Biosciences of California, Inc.
NASDAQ:PACB
$436.40M
Community Health Systems, Inc.
NYSE:CYH
$430.50M
Orthofix Medical Inc.
NASDAQ:OFIX
$372.28M
DarioHealth Corp.
NASDAQ:DRIO
$50.46M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does AIRS generate?
AirSculpt Technologies, Inc. (AIRS) reported $151.82M of revenue in fiscal 2025.
Is AIRS profitable?
AirSculpt Technologies, Inc. (AIRS) reported -$11,667,000.00 of net income, with a net margin of -7.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.